by penningtoncapital | Sep 22, 2015 | Market News
Biotech markets have been in flux ever since Democratic presidential candidate Hillary Clinton tweeted a 20-word opinion of Martin Shkreli. Her statement, decrying biotech and big pharma for their pricing policy, caused an upset that continues to ripple even now....
